Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DocGo (DCGO) Asset Writedowns and Impairment (2021 - 2025)

DocGo (DCGO) has 5 years of Asset Writedowns and Impairment data on record, last reported at $5.5 million in Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment rose 408.67% year-over-year to $5.5 million; the TTM value through Sep 2025 reached $12.5 million, up 199.11%, while the annual FY2024 figure was $8.3 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached $5.5 million in Q3 2025 per DCGO's latest filing, up from $1.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $5.5 million in Q3 2025 and bottomed at -$1.9 million in Q1 2023.
  • Average Asset Writedowns and Impairment over 5 years is $1.3 million, with a median of $1.1 million recorded in 2022.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 264.84% in 2023, then surged 1328.56% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $2.3 million in 2021, then crashed by 51.97% to $1.1 million in 2022, then tumbled by 72.0% to $311441.0 in 2023, then soared by 1328.56% to $4.4 million in 2024, then rose by 24.26% to $5.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $5.5 million in Q3 2025, $1.2 million in Q2 2025, and $1.2 million in Q1 2025.